Molecular Predictors of Outcome with Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer: Data from the Randomized Phase Ⅲ INTEREST Trial

YANG Jin-ji; ZHANG  Yi-fang

doi:10.3969/j.issn.1671-5144.2011.01.018

YANG Jin-ji, ZHANG Yi-fang. Molecular Predictors of Outcome with Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer: Data from the Randomized Phase Ⅲ INTEREST Trial[J]. Journal of Evidence-Based Medicine, 2011, 11(1): 34-38. DOI: 10.3969/j.issn.1671-5144.2011.01.018

Citation:

YANG Jin-ji, ZHANG Yi-fang. Molecular Predictors of Outcome with Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer: Data from the Randomized Phase Ⅲ INTEREST Trial[J]. Journal of Evidence-Based Medicine, 2011, 11(1): 34-38. DOI: 10.3969/j.issn.1671-5144.2011.01.018

Citation:

YANG Jin-ji, ZHANG Yi-fang. Molecular Predictors of Outcome with Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer: Data from the Randomized Phase Ⅲ INTEREST Trial[J]. Journal of Evidence-Based Medicine, 2011, 11(1): 34-38. DOI: 10.3969/j.issn.1671-5144.2011.01.018

Molecular Predictors of Outcome with Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer: Data from the Randomized Phase Ⅲ INTEREST Trial

Graphical Abstract

Abstract

FullText(HTML)

References (13)

Molecular Predictors of Outcome with Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer: Data from the Randomized Phase Ⅲ INTEREST Trial

Catalog

Export File

Citation

Format

Content